Illumina beats estimates for the eighth straight quarter


Oct 21 (Reuters) - Gene sequencing products maker IlluminaInc beat analysts' estimates for the eighth straightquarter on strong sales.

Third-quarter net income rose to $31.4 million, or 22 centsper share, from $29.7 million, or 22 cents per share, a yearearlier.

Total revenue jumped 25 percent to $357 million.

Analysts on average had expected a profit of 40 cents pershare, according to Thomson Reuters I/B/E/S.

View Comments (0)